TAIPEI, Taiwan, March 18, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174) today announced preclinical data for OBI-992, a potential best-in-class anti-TROP2 Antibody-Drug Conjugate (ADC). When evaluated against comparative TROP2 ADCs, ...
Read MoreCANTON, Mich. (March 14, 2024) - TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ...
Read More36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third of respondents are now actively tracking their sleep patterns, ...
Read MoreRelation Therap eutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm London, March 2024 – Relation Therapeutics, a biotechnology company at the forefront of leveraging computational ...
Read MoreSEOUL, South Korea, March 13, 2024 (GLOBE NEWSWIRE) -- Epic Corporation operates Epic One, a luxury secondhand trading platform based in South Korea. The company achieved an annual revenue of $17 million dollars (19 billion KRW) last year ...
Read MoreSUNNYVALE, Calif. , March 18, 2024 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone with initiation of its ...
Read MoreSHENZHEN, China , March 18, 2024 /PRNewswire/ -- On March 18 2024, Shenzhen chipscreen biosciences Co., Ltd. (hereinafter referred to as "chipscreen biosciences", stock code: 688321. SH) announced that the Phase II clinical trial ...
Read MoreCANTON, Mich. (March 14, 2024) - TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ...
Read MoreTEL AVIV, Israel , March 15, 2024 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases announced today the grant of a ...
Read MoreThe Australian Health and Wellness Brand Offers Natural Preventative Solutions to Stay Healthy This Winter FORT LAUDERDALE, Fla. , March 15, 2024 /PRNewswire/ -- The winter is a season filled with germs, viruses, and bacteria — a reality ...
Read MoreZHUHAI, China , March 15, 2024 /PRNewswire/ -- On March 14, 2024 , Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics for oncology and inflammatory diseases, and Hansoh ...
Read MoreTAMPERE, Finland , March 14, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has today been granted Breakthrough Device Designation for its RemeOs™ Spinal Interbody Cage implant from the US Food and Drug ...
Read MoreNEW YORK , March 14, 2024 /PRNewswire/ -- In a collaborative effort, Double Board Certified New York Facial Plastic Surgeon, Sam Rizk , MD, FACS , teams up with esteemed colleague Double Board Certified Chicago Facial Plastic Surgeon ...
Read MorePartnership with leading US-based ALS patient advocacy group furthers myTomorrows' mission of ensuring that patients confronting life-threatening diseases are aware of all possible treatment options NEW YORK , March 14, 2024 /PRNewswire/ ...
Read MoreFN Media Group Presents USA News Group News Commentary VANCOUVER, BC , March 14, 2024 /PRNewswire/ -- USA News Group - Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate ...
Read MoreIntroducing a cleaner, greener way to enjoy hemp smokeables: Biodegradable hemp filters and rechargeable vape batteries DALLAS , March 14, 2024 /PRNewswire-PRWeb/ -- Coast Smokes collaborates with Willie Nelson's legendary hemp brand, ...
Read MorePhase 1 Study Led by World-Renowned Expert Prof. Felice Petraglia to Evaluate Gynica's Non-Hormonal, Intra-Vaginal Drug Candidates In perfect timing with Endometriosis Awareness Month, the announcement of the study is one step forward for ...
Read MoreCo-led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc. with participation from existing investors Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden Lead program is AT-108, a first-in-class, off-the-shelf ...
Read Morehttps://news.cision.com/bioservo-ab/i/table-1-measures-on-difficulty-in-chosen-activities,c3278007 Table 1 Measures on difficulty in chosen activities https://news.cision.com/bioservo-ab/i/gcom-2024-presentation,c3278171 ...
Read MoreThe study, conducted in collaboration with the Cleveland Clinic, demonstrates Circadia Health's C100 system's ability to offer continuous, contactless respiratory monitoring, predicting clinical deterioration 24 hours in advance and enhancing ...
Read MoreKANSAS CITY, Mo. and WILMINGTON, Del. , March 13, 2024 /PRNewswire/ -- Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing ...
Read MoreBlinded Safety Review Completed for the First 6 Months of the Phase 2a Clinical Trial Conduct; Recommending Trial Continue Without Modification Full Data Readout Expected in the Second Half of 2024 CAMBRIDGE, Mass. , March 13, 2024 ...
Read MoreSTIMULAN®, when mixed with antibiotics, can be used for the treatment of bacterial infection STIMULAN® will be distributed exclusively by Bone Surgical in Brazil KEELE, England , March 13, 2024 /PRNewswire/ -- Biocomposites, an ...
Read MoreSHANGHAI , March 12, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present results of three preclinical studies as poster presentation at the AACR ...
Read MoreeRAMx Safeguards Drug Test Integrity with Features for Observation Quality INDIANAPOLIS , March 12, 2024 /PRNewswire/ -- Innovations in remote drug testing technology are allowing observers to actively improve a testing environment, ...
Read MorePromising New Therapy for Sarcomas Could Reduce Reliance on Surgery, Chemotherapy and other Invasive and Toxic Treatments CLEVELAND , March 12, 2024 /PRNewswire/ -- Lamassu Bio Inc., a cutting-edge biotech company dedicated to ...
Read MoreData presented by the MS team at Hadassah Medical Center, Jerusalem , led by Prof. Dimitrios Karussis, in the Americas Committee for Treatment and Research in Multiple Sclerosis Forum reveal consistent reductions in serum levels of both NfL ...
Read MoreOTTAWA, ON , March 11, 2024 /CNW/ - Starting today, oral health providers can confirm their participation in the CDCP through the Sun Life portal . In choosing to participate in the CDCP, oral health care providers are playing an important ...
Read MorePLEASANTON, Calif. , March 11, 2024 /PRNewswire/ -- DiaCarta, a leading molecular diagnostics company specializing in personalized patient care through liquid biopsy, proudly announced that Florida Health Department selected "using plasma ...
Read MoreThe Canadian venture capital fund CTI Life Sciences Fund III, Inveready and the EIC Fund from the European Commission close a round with the additional participation of CDTI Innvierte, FiTalent, family offices as well as founders. BARCELONA, ...
Read MoreYANTAI, China , March 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently gave an oral presentation on an interim analysis of the evaluation of the ...
Read MoreHANGZHOU and SHAOXING, China , March 10, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the poster presentation of Phase II study final results of ASC40, a first-in-class fatty acid synthase (FASN) ...
Read MoreATLANTA , March 8, 2024 /PRNewswire/ -- OrthoVentions LLC today announced its investment in Motio OV , an early-stage company created in partnership with the Hospital for Special Surgery (HSS). Motio OV is developing a novel 3D printed ...
Read MoreCAMBRIDGE, Mass. , March 8, 2024 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a clinical-stage global biopharmaceutical company powered by a cutting-edge drug discovery engine and differentiated clinical development pipeline, today ...
Read MoreBoard-certified dermatologist discusses occupational risks of skin cancer for those who serve SAN DIEGO , March 8, 2024 /PRNewswire/ -- U.S. veterans are at a higher risk of developing melanoma, one of the deadliest forms of skin ...
Read MoreSubscribe to our Free Newsletters!